Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Enterprise Value (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Enterprise Value for 16 consecutive years, with -$91.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Enterprise Value rose 74.82% to -$91.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$91.9 million, a 74.82% increase, with the full-year FY2024 number at -$127.5 million, up 61.4% from a year prior.
  • Enterprise Value was -$91.9 million for Q3 2025 at Usana Health Sciences, up from -$96.8 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$91.9 million in Q3 2025 to a low of -$364.9 million in Q3 2024.
  • A 5-year average of -$251.3 million and a median of -$261.2 million in 2021 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: crashed 32.83% in 2021, then soared 74.82% in 2025.
  • Usana Health Sciences' Enterprise Value stood at -$248.7 million in 2021, then fell by 15.97% to -$288.4 million in 2022, then fell by 14.56% to -$330.4 million in 2023, then skyrocketed by 61.4% to -$127.5 million in 2024, then increased by 27.97% to -$91.9 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Enterprise Value are -$91.9 million (Q3 2025), -$96.8 million (Q2 2025), and -$125.5 million (Q1 2025).